Literature DB >> 24445823

Occurrence of 3 Bordetella species during an outbreak of cough illness in Ohio: epidemiology, clinical features, laboratory findings and antimicrobial susceptibility.

Kevin B Spicer1, Doug Salamon, Carol Cummins, Amy Leber, Loren E Rodgers, Mario J Marcon.   

Abstract

BACKGROUND: An increase in laboratory diagnosis of pertussis was noted in central Ohio during 2010. Diagnosis was made using a polymerase chain reaction assay targeting the multicopy insertion sequence IS481, which is found in both Bordetella pertussis (Bp) and Bordetella holmesii (Bh). An increase in specimens testing positive for Bordetella parapertussis (Bpp) using insertion sequence IS1001 was also noted.
METHODS: Nasopharyngeal swab specimens submitted April 1, 2010, to March 31, 2011, were tested using a multiplex polymerase chain reaction assay for Bp/Bh (IS481) and Bpp followed by singleplex assays for Bp and Bh. A subgroup of specimens was also cultured for Bordetella species, and antimicrobial susceptibility testing was performed on recovered organisms. Demographic and clinical features were compared for patients with Bp, Bh and Bpp.
RESULTS: Of 520 IS481-positive specimens, 214 (41.1%) were positive for Bp, 79 (15.2%) were positive for Bh and 5 (1.0%) were positive for both Bp and Bh; 222 (42.7%) were negative for both targets. An additional 220 specimens were positive for Bpp. Among a sample of 155 IS481-positive specimens, 40, 15 and 0 were culture positive for Bp, Bh and Bpp, respectively. Among a sample of 55 BparaIS1001-positive (Bpp) specimens, 22, 0 and 0 were culture positive for Bpp, Bp and Bh, respectively. All Bordetella species were susceptible to macrolide antibiotics. Patients with Bh were older than patients with Bp, who were older than those positive for Bpp (mean ages: 12.0, 8.0 and 4.2 years, respectively; P < 0.001). One or more classic signs of pertussis (ie, paroxysmal cough, whoop, post-tussive emesis) were seen in 55.9% of 263 patients (59 Bp, 24 Bh, 80 Bpp and 100 negative for Bordetella species), but did not differ statistically among the groups (χ = 5.1, P = 0.17).
CONCLUSIONS: All 3 Bordetella species, Bp, Bh and Bpp, were detected during on outbreak of pertussis-like cough illness. There were noted differences in age and seasonality, but clinical features at the time of presentation did not allow clear differentiation of these infections. All Bordetella species recovered from culture and tested were susceptible in vitro to macrolide antibiotics. Additional study is necessary to further characterize epidemiologic and clinical characteristics of Bh-associated cough illness and to determine potential co-occurrence of Bordetella species with other bacterial and viral respiratory tract pathogens.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24445823     DOI: 10.1097/INF.0000000000000262

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  Bordetella parapertussis survives inside human macrophages in lipid raft-enriched phagosomes.

Authors:  Juan Gorgojo; Eric T Harvill; Maria Eugenia Rodríguez
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

Review 2.  Laboratory Diagnosis of Pertussis.

Authors:  Anneke van der Zee; Joop F P Schellekens; Frits R Mooi
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

3.  Widespread Bordetella parapertussis Infections-Wisconsin, 2011-2012: Clinical and Epidemiologic Features and Antibiotic Use for Treatment and Prevention.

Authors:  Ruth Koepke; Michael L Bartholomew; Jens C Eickhoff; Roman A Ayele; Diane Rodd; Joan Kuennen; Jean Rosekrans; David M Warshauer; James H Conway; Jeffrey P Davis
Journal:  Clin Infect Dis       Date:  2015-06-25       Impact factor: 9.079

Review 4.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

5.  Pertussis outbreak, southeastern Minnesota, 2012.

Authors:  Alexander G Theofiles; Scott A Cunningham; Nicholas Chia; Patricio R Jeraldo; Daniel J Quest; Jayawant N Mandrekar; Robin Patel
Journal:  Mayo Clin Proc       Date:  2014-10       Impact factor: 7.616

6.  Bordetella pertussis: an underreported pathogen in pediatric respiratory infections, a prospective cohort study.

Authors:  Gertrude van den Brink; Jérôme O Wishaupt; Jacob C Douma; Nico G Hartwig; Florens G A Versteegh
Journal:  BMC Infect Dis       Date:  2014-09-30       Impact factor: 3.090

7.  Multicenter Evaluation of BioFire FilmArray Respiratory Panel 2 for Detection of Viruses and Bacteria in Nasopharyngeal Swab Samples.

Authors:  Amy L Leber; Kathy Everhart; Judy A Daly; Aubrey Hopper; Amanda Harrington; Paul Schreckenberger; Kathleen McKinley; Matthew Jones; Kristen Holmberg; Bart Kensinger
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

8.  Conserved Patterns of Symmetric Inversion in the Genome Evolution of Bordetella Respiratory Pathogens.

Authors:  Michael R Weigand; Yanhui Peng; Dhwani Batra; Mark Burroughs; Jamie K Davis; Kristen Knipe; Vladimir N Loparev; Taccara Johnson; Phalasy Juieng; Lori A Rowe; Mili Sheth; Kevin Tang; Yvette Unoarumhi; Margaret M Williams; M Lucia Tondella
Journal:  mSystems       Date:  2019-11-19       Impact factor: 6.496

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.